Oncternal Therapeutics Inc
NASDAQ:ONCT

Watchlist Manager
Oncternal Therapeutics Inc Logo
Oncternal Therapeutics Inc
NASDAQ:ONCT
Watchlist
Price: 0.5266 USD Market Closed
Market Cap: 1.6m USD

Wall Street
Price Targets

ONCT Price Targets Summary
Oncternal Therapeutics Inc

There are no price targets for ONCT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Oncternal Therapeutics Inc Competitors:
Price Targets
ARMP
Armata Pharmaceuticals Inc
47% Upside
ALEC
Alector Inc
38% Upside
CANTA
Cantargia AB
92% Upside
IMDX
Insight Molecular Diagnostics Inc
2% Upside
QTTB
Homology Medicines Inc
261% Upside
KURN
Kuros Biosciences AG
29% Upside
ANAB
AnaptysBio Inc
21% Upside
IMMU
Mendus AB (publ)
210% Upside

Revenue
Forecast

Revenue Estimate
Oncternal Therapeutics Inc

The compound annual growth rate of Oncternal Therapeutics Inc's revenue for the next 3 years is 9%.

N/A
Past Growth
9%
Estimated Growth
Estimates Accuracy
7%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Oncternal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Oncternal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONCT's stock price target?
Not Available

ONCT doesn't have any price targets made by Wall Street professionals.

What is Oncternal Therapeutics Inc's Revenue forecast?
Projected CAGR
9%

The compound annual growth rate of Oncternal Therapeutics Inc's revenue for the next 3 years is 9%.

Back to Top